Table 1.
Complete demographic information for postmortem subjectsa
| Group | Gender | Age (yr) | Postmortem interval (hr) | pH | Psychiatric medication last 3 months |
|---|---|---|---|---|---|
| Control | Male | 48 | 14 | 6.25 | Nil |
| Control | Male | 20 | 12 | 6.3 | No |
| Control | Female | 51 | 20 | 6.5 | NA |
| Control | Male | 59 | 23.5 | 6.76 | NA |
| Control | Female | 49 | 9 | 6.81 | NA |
| Control | Male | 37 | 10 | 6.7 | Nil |
| Control | Male | 52 | 10 | 6.11 | Nil |
| Control | Male | 55 | 21 | 6.7 | Nil |
| Mean ± SEM | 46.38 ± 4.39 | 14.94 ± 2.02 | 6.52 ± 0.09 | ||
| Suicide/MDD | Male | 48 | 15 | 6.78 | NA |
| Suicide/MDD | Male | 22 | 24 | 6.68 | Antidepressants (SNRI), anticonvulsant, benzodiazepines |
| Suicide/MDD | Female | 55 | 36 | 6.79 | Antidepressants (SNRI) |
| Suicide/MDD | Male | 63 | 24 | 6.6 | Classic antidepressants |
| Suicide/MDD | Female | 49 | 14.5 | 7.5 | Antidepressants (SSRI), benzodiazepines |
| Suicide/MDD | Male | 34 | 10.5 | 7 | Antidepressants (SSRI), benzodiazepines |
| Suicide/MDD | Male | 49 | 2.5 | 7 | Nil |
| Suicide/MDD | Male | 52 | 9.5 | 6.7 | Nil |
| Mean ± SEM | 46.38 ± 4.52 | 17 ± 3.73 | 6.78 ± 0.13 | ||
aNo, According to our information, the subject was not taking medication during the last 3 months before death; Nil, no medication; SNRI, serotonin norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor.